Skip to content
May 9, 2025
Latest
“Smaller opportunistic” acquisitions likely to follow DoorDash purchase of Deliveroo, says Glovo founder
London-based Tripledot Studios acquires AppLovin’s gaming portfolio in $800M deal
Bosch launches €250M venture fund to back deeptech startups
7% tax, fast registration, and female leadership: Moldova’s startup scene has arrived
Startups, sustainability, and investment: Austria’s innovation engine
EU Information Service
Good news from around Europe
Home
Startups
EU Funding
About
Promote your project
Home
Startups
EU Funding
About
Promote your project
Search for:
Home
Tech
Research Headlines – BLUEPRINT for research success in blood disease therapy
Research Headlines – BLUEPRINT for research success in blood disease therapy
On
August 24, 2017
By
admin
The EU-funded BLUEPRINT project has generated extensive epigenome data on healthy and diseased blood cells, developed new analysis methods and uncovered new information on how the innate immune system works.
Powered by
WPeMatico
Share this:
Click to share on Facebook (Opens in new window)
Click to share on Twitter (Opens in new window)
Click to share on LinkedIn (Opens in new window)
Click to email a link to a friend (Opens in new window)
Click to print (Opens in new window)
Related
Post navigation
PREVIOUS POST
Previous post:
Success Stories – More sustainable, healthier wine? We’ll drink to that!
NEXT POST
Next post:
Eight European Regios are working together for a #circular #economy in the #interreg project @CircEconomy. Together we find #opportunities.